Glen Harbor Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $969K | Hold |
2,912
| – | – | 0.02% | 480 |
|
|
2019
Q2 | $910K | Hold |
2,912
| – | – | 0.02% | 509 |
|
|
2019
Q1 | $890K | Sell |
2,912
-560
| -16% | -$171K | 0.02% | 490 |
|
|
2018
Q4 | $806K | Sell |
3,472
-140
| -4% | -$32.5K | 0.02% | 478 |
|
|
2018
Q3 | $1.13M | Buy |
3,612
+1,232
| +52% | +$385K | 0.02% | 443 |
|
|
2018
Q2 | $687K | Hold |
2,380
| – | – | 0.01% | 544 |
|
|
2018
Q1 | $595K | Hold |
2,380
| – | – | 0.01% | 575 |
|
|
2017
Q4 | $568K | Buy |
2,380
+224
| +10% | +$53.5K | 0.01% | 603 |
|
|
2017
Q3 | $479K | Buy |
2,156
+252
| +13% | +$56K | 0.01% | 607 |
|
|
2017
Q2 | $431K | Buy |
1,904
+784
| +70% | +$177K | 0.01% | 631 |
|
|
2017
Q1 | $223K | Buy |
1,120
+168
| +18% | +$33.5K | 0.01% | 713 |
|
|
2016
Q4 | $174K | Buy |
+952
| New | +$174K | ﹤0.01% | 725 |
|